Manufacturing

Health crises generate support for new vaccines and treatments for diseases found in developing nations.

Pfizer uses green-chemistry in a second-generation manufacturing route for gabapentin.

The authors describe a comprehensive methodology for establishing functional equivalence among various lyophilizers.

As new process validation guidelines emerge, industry needs to reinvent how it releases product.

Designated as a "pharmerging market," Brazil is revamping its pricing models.

The author describes the approach taken to develop a facility dedicated to handling potent and cytotoxic drug substances.

A Project Manager's Perspective.

The authors discuss the advantages of microreactors and flow chemistry for various reaction types in achieving improved process economics and reaction efficiency.

The author reviews the major biopharmaceutical markets' activity and predicts how the markets may evolve.

Thomas LaVake, manager, worldwide environment, health &safety at Johnson & Johnson, provides a perspective of sustainability practices for the pharmaceutical industry.

Scientists from DSM and Kaneka discuss various techniques in this roundtable moderated by Patricia Van Arnum.

Smoller talks about the benefits of targeted knockout rats.

Combination products have been researched and administered for many years, some successfully and others not.

Combining drugs with synergistic mechanisms of action yields some indisputable benefits; improved efficacy, reduced dosing, enhanced patient compliance, to name just a few.

Increase your chances of success in the biggest market in the world.

Belgium is one of the largest centres for pharmaceutical distribution and has the second highest number of pharma exports per capita worldwide.

Why correctly calibrating a drug with its packaging is the key to success.

The current economic downturn has been described as the worst since the Great Depression and no industry has been left unaffected.

The Czech Republic will no longer purchase the H1N1 flu vaccine from Baxter International.

Scientists have modified a tobacco plant to produce a vaccine for norovirus, the viral infection sometimes referred to as the "cruise ship virus".

Lonza (Basel) has submitted a non-binding proposal that would see it acquire all of the Restricted Voting Shares of US-based Patheon.

Scientists have modified a tobacco plant to produce a vaccine for norovirus, the viral infection sometimes called the "cruise ship virus."

Researchers at the J. Craig Venter Institute (JCVI), a genomic research organization, reported that they successfully transformed one bacterium into a different strain by transferring the entire bacterial genome of the first strain into a second, related strain of bacteria.

Company and People Notes: UCB and Novartis form agreement; AAIPharma appoints VP of regulatory affairs; more...

Researchers from a university in the US are urging the FDA to demand that drug manufacturers state how new medications compare with similar treatments on product labels.

Amcor (Australia) has made an offer of $2025 million for parts of Alcan Packaging (France), including the company's global pharmaceuticals division.

NIR Prediction of Solid Dosage Form Dissolution Profiles - Foss Whitepaper

Also, FDA publishes draft guidances of two ICH Annexes; EMEA sets format for compliance advice; more...

Researchers from the Stanford University School of Medicine in California are urging the US Food and Drug Administration to demand that drug manufacturers state how new medications compare with similar treatments on product labels.

India accounts for approximately 3% of the global outsourcing market, which indicates a significant opportunity for growth, according to a report published by Ernst and Young and the Organization of Pharmaceutical Producers of India.